How accurate is it (really) when trying to simulate AD in rat models? It currently seems to be the 'gold' standard of measurement in labs, but Scopolamine is just an anticholinergic (blocks transmission of acetylcholine); how exactly does treating rats with it simulate the neural tissue damage, hippocampal shrinking, and all the other horrible nastiness that occurs in the symptoms of people suffering from AD?
Scopolamine as a method of testing Alzheimer's?
Started by
Xenix
, Apr 21 2013 11:36 AM
scopolamine alzheimers disease rat models
1 reply to this topic
#1
Posted 21 April 2013 - 11:36 AM
How accurate is it (really) when trying to simulate AD in rat models? It currently seems to be the 'gold' standard of measurement in labs, but Scopolamine is just an anticholinergic (blocks transmission of acetylcholine); how exactly does treating rats with it simulate the neural tissue damage, hippocampal shrinking, and all the other horrible nastiness that occurs in the symptoms of people suffering from AD?
#2
Posted 21 April 2013 - 08:01 PM
As far as I know there is genetic models for AD in rats with increased amyloid accumulation.
like this
http://www.ncbi.nlm....pubmed/23575824
like this
http://www.ncbi.nlm....pubmed/23575824
Also tagged with one or more of these keywords: scopolamine, alzheimers, disease, rat models
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users














